Avalyn Pharma Stock
Avalyn is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including idiopathic pulmonary fibrosis and other interstitial lung diseases.
Sign up for SecondMarket™ to view the market and buy or sell Avalyn Pharma Stock
Buy + SellSee Avalyn Pharma Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Avalyn Pharma Stock Valuation + Share Prices
View real-time Tape D™ data on Avalyn Pharma stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedAvalyn Pharma Management Team
Chief Medical Officer
Howard Lazarus
Director
Ketan Patel
Director
Gianna Hoffman-Luca
Director
Jill Carroll
Chief Operating Officer
Melissa Rhodes
Director
Niall O'Donnell
Director
Jonathan Leff
Director
Tiba Aynechi
Founder, Chief Scientific Officer
Mark Surber
CEO, Director
Lyn Baranowski
Director
Scott Beardsley
Avalyn Pharma Major Investors
Surveyor Capital - Citadel
Perceptive Xontogeny Venture Funds
Pivotal bioVenture Partners LLC
RiverVest Venture Partners LLC
Piper Heartland Healthcare Capital
Edmond de Rothschild Investment Partners SAS
T. Rowe Price Associates, Inc.
TPG Biotech
Catalio Capital Management, LP
Eventide Asset Management LLC
F-Prime Capital Partners
Rock Springs Capital
SR One Ltd
Novo Holdings
Vida Ventures
Wellington Management Company LLP
Norwest Venture Partners
Learn More About Avalyn Pharma Stock
Buy Avalyn Pharma Stock
01Avalyn Pharma stock does not trade on public stock exchanges. Avalyn Pharma stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Avalyn Pharma stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Avalyn Pharma Stock
02Avalyn Pharma Stock does not trade on public stock exchanges. In order to sell Avalyn Pharma shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Avalyn Pharma Stock Price
03Avalyn Pharma does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Avalyn Pharma share price and other valuable private market data.
Read more about secondary market private company stock prices:
Avalyn Pharma Stock Ticker Symbol
04There is no ticker symbol for Avalyn Pharma stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Avalyn Pharma Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Avalyn Pharma stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Avalyn Pharma Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Avalyn Pharma stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Avalyn Pharma Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Avalyn Pharma IPO
08Avalyn Pharma is a private company and has not had an IPO. There is currently no Avalyn Pharma IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Avalyn Pharma IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Avalyn Pharma Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.